BEYİN TÜMÖRÜ TEDAVİSİNDE KULLANILMAK ÜZERE NARİNGİN YÜKLÜ SPANLASTİK FORMÜLASYONLARININ TASARLANMASI VE İN VİTRO DEĞERLENDİRİLMESİ

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Sağlık Bilimleri Enstitüsü

Abstract

Bilgic, I., Design and In Vitro Evaluation of Naringin-Loaded Spanlastic Formulations for Use in the Treatment of Brain Tumors, Master’s Thesis, Graduate School of Health Sciences, Hacettepe University, Pharmaceutical Technology Program, Ankara, 2026. Brain tumors, particularly glioblastoma (GBM), pose a significant health problem due to their aggressive course—characterized by rapid proliferation and high invasiveness—as well as high recurrence rates and the development of resistance to current treatments. The blood-brain barrier and blood-tumor barrier make it difficult for therapeutic agents to reach tumor tissue at sufficient concentrations. In recent years, intensive research has been conducted on nanotechnology-based drug delivery systems, such as spanlastics, to overcome these difficulties. Naringin (NAR), a naturally occurring flavanone glycoside known for its anticancer effect, has limited therapeutic use due to its low water solubility and limited bioavailability. The aim of this thesis is to design spanlastic formulations to improve the biopharmaceutical properties of NAR and provide a long-term release profile for use in the treatment of brain tumors. In this study, characterization studies were carried out by examining critical quality parameters such as vesicle size, polydispersity index, zeta potential, encapsulation efficiency, elasticity, and in vitro drug release properties of NAR-loaded spanlastic formulations prepared by ethanol injection and optimized with factorial design. Based on the findings, the optimum formulation was determined and its cytotoxic efficacy on the RG2 glioblastoma cell line was evaluated. The aim is for the developed optimum spanlastic formulation to provide extended drug release compared to free NAR, to increase the therapeutic potential of the active substance, and to offer an alternative approach to overcoming biological barriers encountered in the treatment of brain tumors. In conclusion, it is considered that the developed spanlastic formulations have the potential to serve as an innovative and promising drug delivery system that could contribute to enhancing antitumor efficacy in the treatment of brain tumors.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By